PENGARUH KOMPLEKSASI INKLUSI ATORVASTATIN DENGAN β-SIKLODEKSTRIN TERHADAP FORMULASI DAN EVALUASI FAST DISINTEGRATING TABLETS (FDT) ATORVASTATIN
Abstract
Full Text:
PDFReferences
Ajmera, A., Deshpande, S., Patel, P., Patel, K., Solanki, S., Rathod, K., 2012, Reverse phase high performance liquid chromatographic method for simultaneous determination of atorvastatin, ezetimibe and fenofibrate in commercial tablets, Int. J. of Pharm. and Pharmaceutical Sci., 4: 206-209.
Akbari, 2011, Effect of Types of Cyclodextrin on Rosuvastatin Calcium Inclusion Complex, IJP, 2: 1-8.
Fernandes, C.M., Vieira, M.T., and Viega, F.J., 2002, Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds, Eur. J. Pharm. Sci., 15: 79–88.
Lablanche, J.M., 2001, Achieving LDL-C target levels: the role of statins, Curr Med Res Opin, 16: 285-295
Loftsson, T., Masson, M., and Brewster, M.E., 2005, Self-Association of Cylodextrin and Cyclodextrin Complexes, J. Pharm. Sci., 93 (9): 1091.
Mura, P; Faucci, M.T; Bettinetti, G.P., 2001, The influence of polyvivylpyrrolidone on naproxen complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci., 13: 187-194.
Nielsen, S. and Nordestgaard, B., 2014, Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study, Lancet Diabetes Endocrinol, 2: 894–900.
Patel, R., Bhimani, D., Patel, J., and Patel, D., 2008, Solid-state characterization and dissolution properties of ezetimibe–siklodkestrins inclusion complexes, J. Incl. Phenom. Macro, 60: 241–251.
Sanjay, 2014, Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastroretentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Susta ined-Release, Int. J. Biomed, 39 (6): 106.
Swati, R., 2004, Solubility enhancement of celecoxibusing β-cyclodextrin inclusion complexes, European Journal of Pharmaceutics and Biopharmaceutics, 57: 263–267.
Singh, S.K., Srinivasan, K.K., Singare, D.S., Gowthamarajan, K., and Prakash, D., 2012, Formulation of ternary complexes of glyburide with hydroxypropyl-β-cyclodextrin and other solubilizing agents and their effect on release behavior of glyburide in aqueous and buffered media at different agitation speeds. Drug Dev Ind Pharm, 38: 1328-1336.
Szejtli, J., 1997, Cyclodextrins in pharmacy, Dordrecht, The Netherlands, Kluwer Academic Publishers.
Zingone, G. and Rubessa, F., 2005, Preformulation study of the inclusion complex warfarin-β-cyclodextrin, Int J. Pharm,. 291 (1–2): 3–10.
DOI: http://dx.doi.org/10.12928/mf.v13i2.7768
Refbacks
- There are currently no refbacks.
Copyright (c) 2019 Universitas Ahmad Dahlan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Media Farmasi
p-ISSN 1412-7946 | e-ISSN 2503-5223
Published by Universitas Ahmad Dahlan Yogyakarta Indonesia
Website: http://journal.uad.ac.id/index.php/Media-Farmasi/index
Email: mediafarmasi@pharm.uad.ac.id
This work is licensed under a Creative Commons Attribution 4.0 International License
View Media Farmasi Stats